Vimarsana
Biggest News Aggregation in the World

Immune Control Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immune Control Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immune Control Unit Today - Breaking & Trending Today

Crucial Role of Early Intervention in Achieving HIV Remission - Vimarsana News

Crucial Role of Early Intervention in Achieving HIV Remission

Early treatment correlates with post-treatment infection control, hinting at a potential window for promoting HIV remission.

Early treatment key to HIV remission: Study - Vimarsana News

Early treatment key to HIV remission: Study

Starting treatment early may promote long-term control of the HIV virus if treatment is not discontinued, finds a study.People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. ...

Mysterious case of the 'Geneva patient,' the latest person in long-term remission from HIV, raises questions - Vimarsana News

Mysterious case of the 'Geneva patient,' the latest person in long-term remission from HIV, raises questions

A man entered long-term remission from HIV after a stem cell transplant, but unlike in previous, similar cases, the patient's transplant donor did not carry an HIV-resistant gene variant.

HIV: a new case of remission after a bone marrow transplant - Vimarsana News

HIV: a new case of remission after a bone marrow transplant

A man designated as "the Geneva patient" is in long remission from HIV. He received a bone marrow transplant that does not have a known mutation to block the virus. His case was presented Thursday in Australia. This is the sixth person likely cured of the infection after receiving a bone bone transplant. The virus remains undetectable 20 months after the interruption of antiretroviral treatment in this patient followed at the University Hospitals of Geneva, in collaboration with the Institut Pasteur and IciStem.